Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Ertl

Showing results (41-50 of 402) with videos related to

Pageof 41
Sort By:
Nature Clinical Practice. Cardiovascular Medicine|July 27, 2007
Mechanisms of disease: Toll-like receptors in cardiovascular diseaseStefan Frantz, Georg Ertl, Johann Bauersachs
Journal of Cardiovascular Pharmacology|October 7, 2020
Therapeutic Monitoring of Direct Oral Anticoagulants-Back to the Future?Kai Hu, Georg Ertl, Peter Nordbeck
Journal of Cardiovascular Pharmacology|November 20, 2004
Effects of high- and low-dose amiodarone on mortality, left ventricular remodeling, and hemodynamics in rats with experimental myocardial infarctionKai Hu, Peter Gaudron, Georg Ertl
Plos One|December 22, 2006
Does FXIII deficiency impair wound healing after myocardial infarction?Matthias Nahrendorf, Ralph Weissleder, Georg Ertl
Cardiovascular Research|November 4, 2008
Post-infarct remodelling: contribution of wound healing and inflammationStefan Frantz, Johann Bauersachs, Georg Ertl
MMW Fortschritte Der Medizin|October 19, 2020
Gülmisal Güder, Christiane Angermann, Georg Ertl
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2016
[Competence Network Heart Failure (CNHF). Together against heart failure]Georg Ertl, Stefan Störk, Rita Börste
Expert Opinion on Therapeutic Targets|March 10, 2011
Toll-like receptors as potential therapeutic targets in cardiac dysfunctionUlrich Hofmann, Georg Ertl, Stefan Frantz
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Toll-like receptor signaling in the ischemic heartStefan Frantz, Georg Ertl, Johann Bauersachs
Der Internist|August 30, 2008
[Notifications of the German Society for Internal Medicine]Georg Ertl, Johann Bauersachs, Stefan Frantz
Pageof 41

Showing results (41-50 of 402) with videos related to

Sort By:
Pageof 41
Nature Clinical Practice. Cardiovascular Medicine|July 27, 2007
Mechanisms of disease: Toll-like receptors in cardiovascular diseaseStefan Frantz, Georg Ertl, Johann Bauersachs
Journal of Cardiovascular Pharmacology|October 7, 2020
Therapeutic Monitoring of Direct Oral Anticoagulants-Back to the Future?Kai Hu, Georg Ertl, Peter Nordbeck
Journal of Cardiovascular Pharmacology|November 20, 2004
Effects of high- and low-dose amiodarone on mortality, left ventricular remodeling, and hemodynamics in rats with experimental myocardial infarctionKai Hu, Peter Gaudron, Georg Ertl
Plos One|December 22, 2006
Does FXIII deficiency impair wound healing after myocardial infarction?Matthias Nahrendorf, Ralph Weissleder, Georg Ertl
Cardiovascular Research|November 4, 2008
Post-infarct remodelling: contribution of wound healing and inflammationStefan Frantz, Johann Bauersachs, Georg Ertl
MMW Fortschritte Der Medizin|October 19, 2020
Gülmisal Güder, Christiane Angermann, Georg Ertl
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 17, 2016
[Competence Network Heart Failure (CNHF). Together against heart failure]Georg Ertl, Stefan Störk, Rita Börste
Expert Opinion on Therapeutic Targets|March 10, 2011
Toll-like receptors as potential therapeutic targets in cardiac dysfunctionUlrich Hofmann, Georg Ertl, Stefan Frantz
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
Toll-like receptor signaling in the ischemic heartStefan Frantz, Georg Ertl, Johann Bauersachs
Der Internist|August 30, 2008
[Notifications of the German Society for Internal Medicine]Georg Ertl, Johann Bauersachs, Stefan Frantz
Pageof 41